Interactions of Ligands at Angiotensin 2-Receptors and Imidazoline Receptors

DOI Web Site Web Site Web Site PubMed 参考文献81件
  • Wethmar Uta
    Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck
  • Raasch Walter
    Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck
  • Dendorfer Andreas
    Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck
  • Dominiak Peter
    Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck

書誌事項

タイトル別名
  • Interactions of Ligands at Angiotensin II-Receptors and Imidazoline Receptors.

この論文をさがす

抄録

Ligands for angiotensin II-(AT)-receptors and imidazoline receptors have structural similarities and influence blood pressure via various mechanisms. The goal of this study was to study the specificity of various ligands by displacement experiments. Antazoline, cimetidine, clonidine, efaroxan, guanabenz, guanethidine, idazoxan, moxonidine and rilmenidine up to a concentration of 100 μM failed to displace the specific binding of [125I]Sar1,Ile8 angiotensin II at the AT1-receptor characterized by losartan (IC50 = 26 ± 12 nM) in liver homogenate. The same substances up to 100 μM produced no reduction of specific [125I]Sar1,Ile8 angiotensin II binding to the AT2-receptor of phaeochromocytoma cell membranes characterized by PD123319 (IC50 = 20 ± 5 nM). Displacement experiments at the imidazoline I1-receptors were performed on bovine adrenal medulla membranes using [3H]clonidine after characterization by the I1-ligand clonidine (IC50 = 459 ± 13 nM) and the I2-ligand idazoxan (IC50 = 3.29 ± 0.88 μM). The investigated AT-receptor ligands angiotensin II, losartan, EXP 3174 and PD123319 revealed no displacement of [3H]clonidine up to a concentration of 100 μM. The I2-receptor in liver homogenate was characterized by displacement of [3H]idazoxan by cold idazoxan and clonidine (IC50 = 0.37 ± 0.17 and 68 ± 31 μM, respectively). The investigated AT-receptor ligands angiotensin II, losartan and PD123319 failed to displace [3H]idazoxan specifically up to 100 μM. Hence, the tested substances showed no cross-reactivity at the corresponding AT- and I-receptors up to 100 μM, a concentration markedly higher than the plasma concentrations achieved after therapeutic application.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 85 (2), 167-174, 2001

    公益社団法人 日本薬理学会

参考文献 (81)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ